2/7/2014

Mela Sciences has secured $12.4 million in its latest funding round. The New York-based optical diagnostics company will use part of the money to reintroduce its MelaFind system, designed to diagnose melanoma, to dermatologists who treat patients at high risk for the condition.

Related Summaries